Provivi® is pleased to announce an agreement with Syngenta Crop Protection AG for the development of a new, natural and sustainable pheromone-based product concept for the effective management of major rice pests in Indonesia.
Provivi® today announced it has completed an $85 million Series C financing.
Provivi™ today announced the hiring of Dr. Timothy (Tim) Taylor, Vice President of Formulation and Tariq Salim, Vice President of Supply Chain.
Provivi™ today announced the successful production of the fall armyworm (Spodoptera frugiperda) pheromone at ton scale.
Provivi™ today announced successful pheromone production scale up at the Bio Base Europe Pilot Plant (BBEPP) in Belgium.
Provivi™ today announced that it has added three senior leaders to its team: William Evanko, Vice President of Engineering; Dr. Thomas Clark, Vice President of Field Development; and Dr. Richard Pederson, Vice President of Chemistry.
Provivi™ today announced a $5 million expansion to a $31.5 million Series B, bringing the round total to $36.5 million.
Provivi™ today announced a multi-year supply agreement with a leading agricultural company. The contract marks Provivi’s largest commercial agreement to date.
Provivi™ co-founder and Caltech Professor Frances Arnold was one of three winners of the Nobel Prize in Chemistry 2018. Arnold, the fifth woman to win a chemistry Nobel in the prize’s 117-year history, split the award with George P. Smith and Gregory P. Winter for their work on harnessing evolution for building new biomolecules.
Provivi™ today announced U.S. EPA registration approval for its first pheromone active ingredient, Provivi™ Z-9-Tetradecenyl Acetate, EPA Reg. No. 91261-1, and also its first end-use product, Provivi™ FAW Dispenser, EPA Reg. No. 91261-2.